Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention
10.1111/j.1540-8183.2005.04031.x
Saved in:
Main Authors: | Razakjr, O.A., Tan, H.C., Yip, W.L., Lim, Y.T. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/117810 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Comparison of safety and efficacy of intracoronary bolus abciximab only vs standard intravenous bolus and infusion abciximab in patients with myocardial infarction undergoing percutaneous coronary intervention
by: Ngo, Minh Hung, et al.
Published: (2016) -
Case Report: Thrombocytopenia in a Patient Undergoing Primary Percutaneous Coronary Intervention
by: Yudi Her Oktaviono, et al.
Published: (2019) -
The use of abciximab in coronary angioplasty - An Asian centre's experience
by: Tan, H.C., et al.
Published: (2014) -
Bleeding Complications of Ultrasound-Guided Pericardiocentesis in the Presence of Coagulopathy or Thrombocytopenia
by: Alexander J. Ryu, et al.
Published: (2020) -
Percutaneous coronary intervention in the elderly: Results from the Thai National Percutaneous Coronary Intervention Registry (TPCIR)
by: Songsak Kiatchoosakun, et al.
Published: (2018)